Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that Dr. Kaushik J. Dave, President and CEO, will present at the Biotech Showcase™ 2014 conference from January 13th to 15th, 2014. Dr. Dave will present a corporate update on Monday, January 13, 2014 at 4:30 pm Pacific.
Help employers find you! Check out all the jobs and post your resume.
